PT - JOURNAL ARTICLE AU - Ryan Arathimos AU - Chiara Fabbri AU - Evangelos Vassos AU - Katrina A S Davis AU - Oliver Pain AU - Alexandra Gillett AU - Jonathan R I Coleman AU - Ken Hanscombe AU - Saskia Hagenaars AU - Bradley Jermy AU - Anne Corbett AU - Clive Ballard AU - Dag Aarsland AU - Byron Creese AU - Cathryn M Lewis TI - Latent subtypes of manic or irritable episode symptoms in two population-based cohorts AID - 10.1101/2021.04.14.21255394 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.14.21255394 4099 - http://medrxiv.org/content/early/2021/07/08/2021.04.14.21255394.short 4100 - http://medrxiv.org/content/early/2021/07/08/2021.04.14.21255394.full AB - Background Episodic changes in mood characterise disorders such as bipolar disorder, which includes distinct periods of manic excitability or irritability, along with additional symptoms experienced during these periods. Common clinical understanding informs diagnostic criteria and epidemiological studies reflect clinical thresholds.Aims To use a data-driven approach to defining groupings of symptoms experienced during periods of manic or irritable mood, which could inform understanding of mood disorders and guide case classification by identifying subgroups with homogeneous clinical/functional outcomes.Methods We used latent class analysis (LCA) to conduct an exploration of the latent structure in symptom responses in the UK Biobank and PROTECT studies, by investigating how symptoms, experienced during periods of manic or irritable mood, formed latent subgroups. We tested associations of latent subgroups with sociodemographic characteristics, diagnoses of psychiatric disorders and polygenic risk scores (PRS).Results Five latent classes were identified that captured patterns of symptoms experienced during periods of manic or irritable mood (N=42,183) in UK Biobank. We identified one class that experienced disruptive episodes of mostly irritable mood that was largely comprised of cases of depression/anxiety, and a class of individuals with increased confidence/creativity that reported lower disruptiveness and lower functional impairment. The five latent classes were replicated in an independent cohort, the PROTECT study (N=4,445), with similar distinctions between classes.Conclusion Our data-driven approach to grouping individuals identified distinct latent classes. A dimensional classification of mood disorders informed by our findings will be able to better assess or subtype these disorders in future studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis paper represents independent research coordinated by the University of Exeter and Kings College London and is funded in part by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London. This research was also supported by the NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula, the NIHR BioResource Centre Maudsley and the NIHR Exeter Clinical Research Facility. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care or Kings College London. We gratefully acknowledge the participation of all National Institute for Health Research (NIHR) BioResource, the NIHR BioResource Centre Maudsley, Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London volunteers, and thank the BioResource staff for their help with volunteer recruitment. Further information can be found at https://www.maudsleybrc.nihr.ac.uk/facilities/bioresource/. This work was funded in part by the University of Exeter through the MRC Proximity to Discovery: Industry Engagement Fund (External Collaboration, Innovation and Entrepreneurism: Translational Medicine in Exeter 2 (EXCITEME2) ref. MC_PC_17189). Genotyping of PROTECT was performed at deCODE Genetics. The authors acknowledge use of the research computing facility at Kings College London, Rosalind (https://rosalind.kcl.ac.uk), which is delivered in partnership with the NIHR Biomedical Research Centre at South London & Maudsley and Guys & St. Thomas NHS Foundation Trusts, and part-funded by capital equipment grants from the Maudsley Charity (Grant Ref. 980) and Guys & St. Thomas Charity (TR130505). Chiara Fabbri was supported by Fondazione Umberto Veronesi (https://www.fondazioneveronesi.it). Saskia Hagenaars was supported by the Medical Research Council (MR/S0151132). This research has been conducted using the UK Biobank Resource under Application Number 18177. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for UK Biobank was granted by the NHS National Research Ethics Committee North West (REC reference 11/NW/0382). Ethical approval for PROTECT was granted by the London Bridge NHS Research Ethics Committee reference number 13/LO/1578.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available from the UK Biobank and PROTECT studies on request from eligible researchers.